Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Price:
0.1601 USD
0.69%
Market Closed
Updated:
Apr 30, 2024
Sonoma Pharmaceuticals Inc
Total Other Income
|
Sonoma Pharmaceuticals Inc
Total Other Income Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
|
Total Other Income
-$679k
|
CAGR 3-Years
-46%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-16%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Total Other Income
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Total Other Income
-$106m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
Pfizer Inc
NYSE:PFE
|
Total Other Income
$1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merck & Co Inc
NYSE:MRK
|
Total Other Income
$917.5m
|
CAGR 3-Years
25%
|
CAGR 5-Years
19%
|
CAGR 10-Years
12%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Total Other Income
$429.2m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
13%
|
CAGR 10-Years
-3%
|
See Also
What is Sonoma Pharmaceuticals Inc's Total Other Income?
Total Other Income
-679k
USD
-679k
USD
Based on the financial report for Dec 31, 2023, Sonoma Pharmaceuticals Inc's Total Other Income amounts to -679k USD.
What is Sonoma Pharmaceuticals Inc's Total Other Income growth rate?
Total Other Income CAGR 10Y
-16%
-16%
Over the last year, the Total Other Income growth was 47%. The average annual Total Other Income growth rates for Sonoma Pharmaceuticals Inc have been -46% over the past three years , -20% over the past five years , and -16% over the past ten years .
You don't have any saved screeners yet
